Delamanid

Delamanid is a nitro-dihydro-imidazooxazole compound that inhibits mycolic acid synthesis in Mycobacterium tuberculosis, used as a component of optimised background regimens for multidrug-resistant tuberculosis. Simson Pharma's Delamanid reference standard and impurities support QC for this critical reserve TB agent.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Delamanid Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Delamanid
Delamanid Piperidine impurity
Delamanid S-Isomer
Delamanid Hydroxy KSM
Delamanid Impurity 1
(R)-1-(2-hydroxy-2-methyl-3-(4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenoxy)propyl)urea
Delamanid Impurity 4
Delamanid Impurity 5
Delamanid Impurity 7
Delamanid Impurity 13
Delamanid Impurity 12
Delamanid Impurity 11
Delamanid Impurity 10
Delamanid Impurity 8
Delamanid Impurity 2
Delamanid Impurity 1 Chloride
Delamanid Impurity 16
Delamanid Impurity 15
Delamanid Impurity 17
Delamanid N-Oxide Impurity 1

Metabolites

M1 metabolite of Delamanid

Isotope Labelled Compounds

Delamanid D4